308 related articles for article (PubMed ID: 24427331)
1. Foxl1 inhibits tumor invasion and predicts outcome in human renal cancer.
Yang FQ; Yang FP; Li W; Liu M; Wang GC; Che JP; Huang JH; Zheng JH
Int J Clin Exp Pathol; 2014; 7(1):110-22. PubMed ID: 24427331
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma.
Xue YJ; Xiao RH; Long DZ; Zou XF; Wang XN; Zhang GX; Yuan YH; Wu GQ; Yang J; Wu YT; Xu H; Liu FL; Liu M
J Transl Med; 2012 Sep; 10():200. PubMed ID: 23006512
[TBL] [Abstract][Full Text] [Related]
3. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
[TBL] [Abstract][Full Text] [Related]
4. FOXL1, a novel candidate tumor suppressor, inhibits tumor aggressiveness and predicts outcome in human pancreatic cancer.
Zhang G; He P; Gaedcke J; Ghadimi BM; Ried T; Yfantis HG; Lee DH; Hanna N; Alexander HR; Hussain SP
Cancer Res; 2013 Sep; 73(17):5416-25. PubMed ID: 23801748
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
Du P; Ye L; Yang Y; Jiang WG
Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
[TBL] [Abstract][Full Text] [Related]
6. Suppression of MMP-9 activity by NDRG2 expression inhibits clear cell renal cell carcinoma invasion.
Ma JJ; Kong LM; Liao CG; Jiang X; Wang Y; Bao TY
Med Oncol; 2012 Dec; 29(5):3306-13. PubMed ID: 22692967
[TBL] [Abstract][Full Text] [Related]
7. Protein phosphatase-2A is down-regulated in patients within clear cell renal cell carcinoma.
Li J; Sheng C; Li W; Zheng JH
Int J Clin Exp Pathol; 2014; 7(3):1147-53. PubMed ID: 24696731
[TBL] [Abstract][Full Text] [Related]
8. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
9. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
[TBL] [Abstract][Full Text] [Related]
10. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
Laba P; Wang J; Zhang J
BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
12. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor.
Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D
Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of forkhead box M1 protein is associated with poor prognosis in clear cell renal cell carcinoma.
Wu XR; Chen YH; Liu DM; Sha JJ; Xuan HQ; Bo JJ; Huang YR
Med Oncol; 2013 Mar; 30(1):346. PubMed ID: 23263830
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X
J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019
[TBL] [Abstract][Full Text] [Related]
15. High kinesin family member 11 expression predicts poor prognosis in patients with clear cell renal cell carcinoma.
Jin Q; Dai Y; Wang Y; Zhang S; Liu G
J Clin Pathol; 2019 May; 72(5):354-362. PubMed ID: 30819726
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of a novel lncRNA CADM1-AS1 is associated with poor prognosis in patients with clear cell renal cell carcinomas.
Yao J; Chen Y; Wang Y; Liu S; Yuan X; Pan F; Geng P
Int J Clin Exp Pathol; 2014; 7(6):2758-67. PubMed ID: 25031695
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of miR-497 is associated with poor prognosis in renal cancer.
Zhao X; Zhao Z; Xu W; Hou J; Du X
Int J Clin Exp Pathol; 2015; 8(1):758-64. PubMed ID: 25755771
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinoma.
Xue S; Li QW; Che JP; Guo Y; Yang FQ; Zheng JH
Int J Clin Exp Pathol; 2015; 8(4):3765-74. PubMed ID: 26097558
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma.
Du Y; Wang Q; Zhang X; Wang X; Qin C; Sheng Z; Yin H; Jiang C; Li J; Xu T
J Exp Clin Cancer Res; 2017 May; 36(1):66. PubMed ID: 28494778
[TBL] [Abstract][Full Text] [Related]
20. Golgi Alpha-Mannosidase II as a Novel Biomarker Predicts Prognosis in Clear Cell Renal Cell Carcinoma.
Li C; Guo L; Chen F; Yu W; Rao T; Ruan Y
Oncol Res Treat; 2020; 43(6):264-275. PubMed ID: 32403105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]